Bill > HB1537

This bill mandates that the Maryland Department of Health's newborn screening system, which is a coordinated statewide program designed to identify hereditary and congenital disorders in newborns that could lead to severe health or developmental problems, must include screening for metachromatic leukodystrophy, a rare genetic disorder. This addition expands the existing requirements for laboratory testing and follow-up activities aimed at early identification and treatment of affected infants, ensuring that this specific condition is now a mandatory part of the comprehensive newborn screening process in Maryland, effective October 1, 2026.